Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.30620402
   PubMed Web of Science ®Google Scholar
• Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463–473. doi:10.1016/j.mcna.2018.12.00630955514
   PubMed Web of Science ®Google Scholar
• Villalobos P, Wistuba II. Lung cancer biomarkers. Hematol Oncol Clin North Am. 2017;31(1):13–29. doi:10.1016/j.hoc.2016.08.00627912828
   PubMed Web of Science ®Google Scholar
• Jotte RM, Spigel DR. Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance. Cancer Med. 2015;4(11):1621–1632.26310719
   PubMed Web of Science ®Google Scholar
• Naylor EC, Desani JK, Chung PK. Targeted therapy and immunotherapy for lung Cancer. Surg Oncol Clin N Am. 2016;25(3):601–609. doi:10.1016/j.soc.2016.02.01127261918
   PubMed Web of Science ®Google Scholar
• Xue Y, Chen R, Qu L, Cao X. Noncoding RNA: from dark matter to bright star. Sci China Life Sci. 2020;63(4):463–468. doi:10.1007/s11427-020-1676-532189240
   PubMed Web of Science ®Google Scholar
• Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36. doi:10.1038/s41568-020-00306-033082563
   PubMed Web of Science ®Google Scholar
• Lekka E, Hall J. Noncoding RNAs in disease. FEBS Lett. 2018;592(17):2884–2900. doi:10.1002/1873-3468.1318229972883
   PubMed Web of Science ®Google Scholar
• Byun Y, Choi YC, Jeong Y, et al. MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells. Cell Mol Biol Lett. 2019;24(1):28. doi:10.1186/s11658-019-0152-231061665
   PubMed Web of Science ®Google Scholar
• Chen Z, Chen X, Lu B, et al. Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression. J Hematol Oncol. 2020;13(1):7. doi:10.1186/s13045-019-0842-231959200
   PubMed Web of Science ®Google Scholar
• Liu C, Yang Z, Deng Z, et al. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3. IUBMB Life. 2018;70(6):536–546. doi:10.1002/iub.175229707897
   PubMed Web of Science ®Google Scholar
• Chen TJ, Gao F, Yang T, et al. LncRNA HOTAIRM1 inhibits the proliferation and invasion of lung adenocarcinoma cells via the miR-498/WWOX axis. Cancer Manag Res. 2020;12:4379–4390. doi:10.2147/CMAR.S24457332606933
   PubMed Web of Science ®Google Scholar
• Kim Y, Kim H, Bang S, Jee S, Jang K. MicroRNA-130b functions as an oncogene and is a predictive marker of poor prognosis in lung adenocarcinoma. Lab Invest. 2021;101(2):155–164. doi:10.1038/s41374-020-00496-z32999430
   PubMed Web of Science ®Google Scholar
• Li J, Yu X, Liu Q, et al. Screening of important lncRNAs associated with the prognosis of lung adenocarcinoma, based on integrated bioinformatics analysis. Mol Med Rep. 2019;19(5):4067–4080.30896819
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang Y. Identification of a long non-coding RNA signature for predicting prognosis and biomarkers in lung adenocarcinoma. Oncol Lett. 2020;19(4):2793–2800.32218832
   PubMed Web of Science ®Google Scholar
• Xin G, Cao X, Zhao W, et al. MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma. Math Biosci Eng. 2020;17(6):8074–8083. doi:10.3934/mbe.202040933378933
   PubMed Web of Science ®Google Scholar
• The Lancet. Lung cancer: some progress, but still a lot more to do. Lancet. 2019;394(10212):1880.
   Web of Science ®Google Scholar
• Kuhn E, Morbini P, Cancellieri A, Damiani S, Cavazza A, Comin CE. Adenocarcinoma classification: patterns and prognosis. Pathologica. 2018;110(1):5–11.30259909
   PubMed Web of Science ®Google Scholar
• Yu W, Zhao Q, Xia C, et al. Validation of stage groupings in the eighth edition of the tumor node metastasis classification for lung adenocarcinoma. Thorac Cancer. 2019;10(3):483–491. doi:10.1111/1759-7714.1296130648815
   PubMed Web of Science ®Google Scholar
• Travis WD, Asamura H, Bankier AA, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11(8):1204–1223. doi:10.1016/j.jtho.2016.03.02527107787
   PubMed Web of Science ®Google Scholar
• Wang L, Anraku M, Sato M, et al. Impact of the 8th edition of the UICC-TNM classification on clinical stage 0-IA lung adenocarcinoma: does the new classification predict postoperative prognosis more precisely than the previous one? Ann Thorac Cardiovasc Surg. 2018;24(5):223–229. doi:10.5761/atcs.oa.18-0005129848840
   PubMed Web of Science ®Google Scholar
• Qu Y, Cheng B, Shao N, et al. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma. Aging. 2020;12(6):4757–4777. doi:10.18632/aging.10287132209727
   PubMedGoogle Scholar
• Jiang H, Xu S, Chen C. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma. BMC Cancer. 2020;20(1):782. doi:10.1186/s12885-020-07235-z32819300
   PubMed Web of Science ®Google Scholar
• Shukla S, Evans JR, Malik R, et al. Development of a RNA-seq based prognostic signature in lung adenocarcinoma. J Natl Cancer Inst. 2017;109(1):djw200.
   PubMedGoogle Scholar
• Ghafouri-Fard S, Shoorei H, Branicki W, Taheri M. Non-coding RNA profile in lung cancer. Exp Mol Pathol. 2020;114:104411. doi:10.1016/j.yexmp.2020.10441132112788
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang D, Wang J, Yu W, Yang J. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8(9):1015.
   PubMed Web of Science ®Google Scholar
• Yin D, Lu X, Su J, et al. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Mol Cancer. 2018;17(1):92. doi:10.1186/s12943-018-0836-729793547
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang H, Chen J, et al. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma. J Cell Biochem. 2019;120(9):15730–15739. doi:10.1002/jcb.2884231050375
   PubMed Web of Science ®Google Scholar
• Liao B, Wang Z, Zhu Y, Wang M, Liu Y. Long noncoding RNA DRAIC acts as a microRNA-122 sponge to facilitate nasopharyngeal carcinoma cell proliferation, migration and invasion via regulating SATB1. Artif Cells Nanomed Biotechnol. 2019;47(1):3585–3597. doi:10.1080/21691401.2019.165663831497998
   PubMed Web of Science ®Google Scholar
• Zhao D, Dong JT. Upregulation of long non-coding RNA DRAIC correlates with adverse features of breast cancer. Noncoding RNA. 2018;4(4):39.
   PubMedGoogle Scholar
• Mu L, Ding K, Tu R, Yang W. Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma. J Transl Med. 2021;19(1):127. doi:10.1186/s12967-021-02800-x33771173
   PubMed Web of Science ®Google Scholar
• Wang C, Tang X, Wang J, Xu Y. Patterns of immune infiltration in lung adenocarcinoma revealed a prognosis-associated microRNA-mast cells network. Hum Cell. 2020;33(1):205–219. doi:10.1007/s13577-019-00300-131863291
   PubMed Web of Science ®Google Scholar
• Sun Y, Su B, Zhang P, et al. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features. Oncol Rep. 2013;29(2):704–712. doi:10.3892/or.2012.215223228962
   PubMed Web of Science ®Google Scholar
• Ren K, Li Y, Lu H, Li Z, Han X. miR-3940-5p functions as a tumor suppressor in non-small cell lung cancer cells by targeting cyclin D1 and ubiquitin specific peptidase-28. Transl Oncol. 2017;10(1):80–89. doi:10.1016/j.tranon.2016.11.00427988424
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109.25159663
   PubMed Web of Science ®Google Scholar
• Chan JJ, Tay Y. Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci. 2018;19(5):1310.
   PubMed Web of Science ®Google Scholar
• Chen R, Wang X, Zhou S, Zeng Z. LncRNA HOXA-AS2 promotes tumor progression by suppressing miR-567 expression in oral squamous cell carcinoma. Cancer Manag Res. 2021;13:5443–5455. doi:10.2147/CMAR.S30594634267554
   PubMed Web of Science ®Google Scholar